Trazimera 420 MG per 20 ML Injectable Solution
- RxCUI
- 2280737
- RxNorm name
- Trazimera 420 MG per 20 ML Injectable Solution
- Display name
- Trazimera 420 MG per 20 ML Injectable Solution
- Full name
- Trazimera 420 MG per 20 ML Injectable Solution
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:18
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761081 | Trazimera | trastuzumab-qyyp | 351(k) Biosimilar | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trazimera | TRASTUZUMAB-QYYP | Pfizer Laboratories Div Pfizer Inc | b9c5e894-27d2-4245-a653-df986fed3c56 | 2026-04-10 | Boxed warning, Warnings, Adverse reactions | 2280737 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b9c5e894-27d2-4245-a653-df986fed3c56 | Trazimera 420 MG in 20 mL Injectable Solution [PSN] · trastuzumab-qyyp 21 MG/ML Injectable Solution [Trazimera] [SBD] · Trazimera 21 MG/ML Injectable Solution [SY] · Trazimera 420 MG per 20 ML Injectable Solution [SY] | 4 | 9 | These highlights do not include all the information needed to use TRAZIMERA safely and effectively. See full prescribing information for TRAZIMERA. TRAZIMERA™ (trastuzumab-qyyp) for injection, for intravenous use Initial U.S. Approval: 2019 TRAZIMERA (trastuzumab-qyyp) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful diff | 20260410 |